Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000652

Type of data
NGS (WGS)
NGS (RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
9.1 TB
File formats
  • FASTQ
Research
hum0344
Date published
2022-08-06
Date modified
2022-08-06
DDBJ Search
JGAD000652 (opens in a new tab)
JGA Study
JGAS000533 (opens in a new tab)

Analysis method

WGS

Materials and participants
Kidney cancer (ICD10: C64) in endo-stage kidney disease: 38 cases (of these, 26 cases also underwent RNA-seq analysis)
tumor tissues: 38 samples
non-tumor tissues/peripheral blood cells: 37 samples
  • Health status
    Affected
  • Subject count
    38 (Individual)
Disease
Kidney cancer (C64)
Sample description
DNAs extracted from tumor tissues and non-tumor tissues/peripheral blood cells from kidney cancer in endo-stage kidney disease
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WGS
Target
N/A
Reagent kit
MGIEasy DNA Library Prep Kit
NEBNext Ultra II FS DNA Module
Fragmentation
Enzymatic fragmentation
Platform
MGI DNBSEQ-G400
Read type
Paired-end
Read length
100 bp
150 bp
Data use policy
NBDC data sharing policy (JGAP000001)

RNA-seq

Materials and participants
Kidney cancer (ICD10: C64) in endo-stage kidney disease: 26 cases (These were also undergone WGS analysis)
tumor tissues: 26 samples
  • Health status
    Affected
  • Subject count
    26 (Individual)
Disease
Kidney cancer (C64)
Sample description
RNAs extracted from tumor tissues from kidney cancer in endo-stage kidney disease
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq Stranded mRNA Library Prep Kit
Fragmentation
Heat treatment
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
126 bp
Data use policy
NBDC data sharing policy (JGAP000001)